BIHC is a Her2-CD3 bispecific antibody, constructed from an anti-Her2 single-domain antibody and an anti-CD3 single-chain variable fragment (Fv) in an IgG-like format. BIHC demonstrates effective in vivo antitumor activity, specifically binding to Her2-expressing tumor cells and efficiently killing Her2-positive cancer cells by recruiting T cells, thus serving as a research tool for Her2-positive cancers.
Molekulargewicht:
492.908
CAS Nummer:
[1642826-40-1]
Formel:
C26H21ClN2O6
Target-Kategorie:
EGFR|||Integrin
T204826
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
